Orchid Design is announcing the launch of its new website, a move designed to achieve additional gains in capabilities awareness and market recognition. Orchid Design states that it is leveraging the industry recognition of parent organization, Orchid Orthopedic Solutions.
Orchid Design Launches New Website
1 min read Premium comments
Secondary
The company indicates that its new website (http://design.orchid-ortho.com) highlights the company’s people, categories of services, and examples of engineering projects in multiple industry segments. Capitalizing on Orchid Design’s customized services for commercializing medical devices are many of the world’s leading surgeon inventors, innovative medical device start-ups, and global orthopedic companies alike.
Orchid Design’s Business Development Manager Kyle Mullens stated in the October 9, 2012 news release, “We’re excited about the launch of our new website and the opportunity it brings to demonstrate Orchid Design’s capabilities and experience to a broader audience. With our team’s clinical experience and broad knowledge of orthopedic devices, we have the expertise and resources to be a valuable development partner, with our new website being one gateway for potential new clients to see where there’s a good fit for their needs.”
Mullens told OTW,
Orchid Design’s site is a newly launched site separate from Orchid Orthopedics corporate site, so the changes are dramatic and focus on our business focus for assisting device companies, entrepreneurs and surgeon inventors with commercializing devices. We’ve highlighted our teams, our categories of services and industry experience with examples of engineering projects in broad industry segments. And within our category of services, there are details on our three core areas of focus—Product Design & Development, Regulatory & Quality Systems, and Prototyping/Customs & Specials.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.